Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Risk factors

After gestational chemotherapy, the kids are all right

When a pregnant woman is diagnosed with cancer, clinical management is complicated by concerns about the possible detrimental effects of cancer treatments on pregnancy outcome and the health of the baby. Evidence about the outcomes of children after maternal chemotherapy for cancer during pregnancy is growing and we can say 'the kids are all right'.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Khöler, C. et al. How much platinum passes the placental barrier? Analysis of platinum applications in 21 patients with cervical cancer during pregnancy. Am. J. Obstet. Gynecol. http://dx.doi.org/10.1016/j.ajog.2015.02.022 (2015).

  2. National Toxicology Program. NTP Monograph: Developmental effects and pregnancy outcomes associated with cancer chemotherapy use during pregnancy. NTP Monogr. 2, i-214 (2013).

  3. Heinonen, K. et al. Late preterm birth and neurocognitive performance in late adulthood: a birth cohort study. Pediatrics http://dx.doi.org/10.1542/peds.2014-3556 (2015).

  4. Shah, P. E., Robbins, N., Coelho, R. B. & Poehlmann, J. The paradox of prematurity: the behavioral vulnerability of late preterm infants and the cognitive susceptibility of very preterm infants at 36 months post-term. Infant Behav. Dev. 36, 50–62 (2013).

    Article  Google Scholar 

  5. Sannia, A. et al. Different gestational ages and changing vulnerability of the premature brain. J. Matern. Fetal Neonatal Med. http://dx.doi.org/10.3109/14767058.2013.796166 (2013).

  6. Cardonick, E. H., Gringlas, M. B., Hunter, K. & Greenspan, J. Development of children born to mothers with cancer during pregnancy: comparing in utero chemotherapy-exposed children with nonexposed controls. Am. J. Obstet. Gynecol. http://dx.doi.org/10.1016/j.ajog.2014.11.032 (2014).

  7. Murthy, R. K. et al. Outcomes of children exposed in utero to chemotherapy for breast cancer. Breast Cancer Res. 16, 3414 (2014).

    Article  Google Scholar 

  8. Amant, F. et al. Long-term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children aged 18 months or older: an observational study. Lancet Oncol. 13, 256–264 (2012).

    Article  CAS  Google Scholar 

  9. Centers for Disease Control and Prevention. Birth Defects: Data & Statistics [online], (accessed 19 March 2015).

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Fedro A. Peccatori.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Peccatori, F., Corrado, G. & Fumagalli, M. After gestational chemotherapy, the kids are all right. Nat Rev Clin Oncol 12, 254–255 (2015). https://doi.org/10.1038/nrclinonc.2015.66

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrclinonc.2015.66

Search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer